Posted by Michael Wonder on 19 Oct 2023
Ruxolitinib phosphate for the treatment of patients with polycythaemia vera
18 October 2023 - NICE has published final evidence based recommendations on the use of ruxolitinib phosphate (Jakavi) for the treatment of patients with polycythaemia vera.
Ruxolitinib phosphate is recommended for the treatment of adults with polycythaemia vera who cannot tolerate hydroxyurea or when the condition is resistant to it.
